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Abstract
Background: Non-communicable diseases (NCDs), malaria and tuberculosis dominate the disease pattern in Myanmar.
Due to urbanization, westernized lifestyle and economic development, it is likely that NCDs such as cerebrovascular
disease and ischemic heart disease are on a rise. The leading behavioral- and metabolic NCDs risk factors are tobacco
smoke, dietary risks and alcohol use, and high blood pressure and body mass index, respectively. The study aimed at
estimating the prevalence and determinants of hypertension, including metabolic-, behavioral- and socio-demographic
risk factors.
Methods: A nationwide, cross-sectional study of 7429 citizens of Myanmar aged 15–64 years were examined in 2009,
using the WHO STEPS methodology. In separate analyses by gender, odds radios (ORs) and 95 % confidence intervals
(CIs) for determinants of hypertension were estimated using logistic regression analyses. Confounders included in
analyses were chosen based on Directed acyclic graphs (DAGs).
Results: The prevalence of hypertension was 30.1 % (95 % CI: 28.4–31.8) in males and 29.8 % (28.5–31.1) in females.
The mean BMI was 21.7 (SD 4.3) kg/m2 for males and 23.0 (5.1) kg/m2 for females. In fully adjusted analyses, we found
in both genders increased OR for hypertension if the participants had high BMI (males: OR = 2.6; 95 % CI 2.1–3.3,
females: OR = 2.3; 2.0–2.7) and high waist circumference (males: OR = 3.4; 1.8–6.8, females: OR = 2.7; 2.2–3.3). In
both sexes, associations were also found between hypertension and low physical activity at work, or living in
urban areas or the delta region. Being underweight and use of sesame oil in cooking was associated with lower
odds for hypertension.
Conclusions: The prevalence of hypertension was high and associated with metabolic-, behavioral- and socio-
demographic factors. Due to expected rapid economic growth in Myanmar we recommend similar studies in the
future to follow up and describe trends in the risk factors, especially modifiable factors, which will most likely be
on rise. Studies on effectiveness on interventions are needed, and policies to reduce the burden of NCD risk factors
should be implemented if proven effective in similar settings.
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Background
Non-communicable diseases (NCDs) and malaria, tuber-
culosis and lower respiratory infections dominate the
disease pattern in Myanmar, along with tobacco smok-
ing, high systolic blood pressure and dietary risks as the
top three NCD risk factors [1]. Due to urbanization,
more westernized lifestyle and economic development in
Myanmar, it is likely that there will be an increase in
daily smokers, alcohol consumption, unhealthy food
habits, physical inactivity, obesity, hypertension and
NCDs such as cerebrovascular disease and ischemic
heart disease [2, 3]. This kind of health transition has
previously been described in the Asian region in coun-
tries under rapid economic development [3].
Socioeconomic improvements, welfare policy and im-
proved public health services are drivers of a country’s
health transition, which is composed by a demographic
transition and an epidemiologic disease transition.
Myanmar is currently implementing several reforms
aiming at improved living conditions of its population.
Concomitant, foreign countries are making investments,
which along with the reforms are leading to economic
growth and further development [1, 4]. When reaching
ordinary people, both will probably impact on the
disease pattern and life expectancy, leading to a reduc-
tion in infectious diseases and an increase in non-
communicable diseases (NCDs). However, similar to
many other countries it is likely that development, and
thus the disease and risk factor pattern, will differ across
urban-rural- and ethnic gradients [3]. It is already docu-
mented that health disparities follow these gradients in
Myanmar [5]. About 70 % of the 50 million population
of Myanmar is currently living in rural areas, and
there are more than 100 different ethnic groups with
Bamar as the dominant one constituting two-thirds of
the total population. Several of the ethnic groups have
distinct cultural hallmarks, and main parts of their
population living in distinct geographical areas, states
or regions.
The long coastline and the fertile land along the many
rivers characterize the geography, and could ensure ac-
cess to seafood and agricultural products for a large pro-
portion of the population. Even in the dry area and the
mountain area, the rivers provide supply of fish. How-
ever, in the border areas to the east, north and north-
west, the access to food is more limited. The differences
in access to food across Myanmar is reflected in high
frequencies of stunting and underweight in some parts
of the country [6]. One fourth of the population lives
below the poverty limit [7], and life expectancy at birth
is 63.6 years for males and 68.5 years for females [8, 9].
The governmental health expenditures was among the
lowest in the world, only 0.89 % of Gross Domestic
Product in the financial year 2013/2014 [4].
Although a recent systematic review and meta-analysis
regarding prevalence, awareness and control of hyper-
tension in Myanmar was published [10], only a limited
number of studies have been conducted.
In the present cross-sectional study of 15–64 year old
citizens of Myanmar who were examined in 2009, the ob-
jectives were to estimate the prevalence of hypertension,
and the associations with selected metabolic-, behavioral-
and socio-demographic determinants of hypertension.
Findings will serve as baseline information, give clues to
targets for interventions, and compared to future data on
NCD risk factors, trends can be estimated, as well as pro-
jections of the burden of NCDs.
Methods
We analyzed original data from the Non-communicable
Disease Risk Factor Survey Myanmar 2009. Further de-
tails on population and methods, selected descriptive re-
sults and questionnaire can be found elsewhere [11].
Population
The inclusion criteria for the study population were ages
of 15–64 years, both genders, and all ethnic groups.
Mentally and physically too ill subjects and retarded pa-
tients, temporary residents (<6 months), and armed
forces personnel, prisoners, hospitalized patients, monks,
and nuns, were not invited to participate.
The sample size was calculated using the formula N =
z2 P (1-P) / e2 where z = α error (5 %); P = prevalence of
major NCD risk factors (50 %); e = precision (5 %) [11].
Thus, N = (1.96)2*(0.5)*(1–0.5)/0.052 = 384. Given sub-
group analyses of 10 groups (5 age groups and 2 sex
groups or urban-rural groups), a cluster sampling design
(described below) with a design effect set at 1.5, and
20 % non-response, the sample size was estimated to be
7200 (N = 384*(5*2)*1.5/(1–0.2)) [11].
The sampling procedure was the multistage cluster
sampling method, with self-weighting sampling proce-
dures. In the first stage, a total of 50 townships from the
four regions (delta, plain, hilly and coastal) of Myanmar
were selected using the probability proportionate to
population size method (PPS). Then, in the second stage,
two wards (urban part of township) and three villages
(rural part of township) were chosen from each town-
ship, using the PPS method, making a total of 100 wards
and 150 villages as secondary sampling units (SSUs). In
the third stage, 22 households were selected randomly
from each ward, and 35 households selected randomly
from each village. In stage two and three, the distribu-
tion of the households selected from each township
followed the urban-rural distribution of the population
in Myanmar, which is about 30:70 [12]. Finally, one per-
son from each household who met the inclusion criteria
was selected using the Kish table. To summarize, there
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were 2200 study participants from urban areas, i.e. the
wards (100 wards x 22 households), and 5250 partici-
pants from rural areas, i.e. the villages (150 villages x 35
households), making a total of 7450 participants. Data
was cleaned, and outliers with values outside the range
set by the WHO STEPwise approach to Surveillance
(STEPS) [13] were excluded giving a total of 7429 partic-
ipants. After exclusion of 110 pregnant women, the final
dataset included 7319 (98.2 %) respondents, and analyses
were performed in accordance with the WHO STEPS
guideline.
Methods
We used data from a household-based cross-sectional
survey, using the WHO STEPS methodology [13].
STEPS is a standardized method for collecting and
processing data, and covers three different levels of
assessment. Step 1 is a questionnaire, step 2 requires
physical measurements, and step 3 consists of bio-
chemical measurements.
Our data include the core and expanded indicators of
both Step 1 and Step 2. The core items contains ques-
tions needed to calculate basic variables, for example
“do you currently smoke any tobacco products”, while
the expanded items asks for more detailed information,
like smoke history in the past and number of cigarettes
smoked every day [14]. The WHO STEPS Instrument
questionnaire was translated into local language for the
different areas in Myanmar and the information was col-
lected by face-to-face interviews. Data were collected
between May and July 2009, and the physical measure-
ments included height, weight, blood pressure, heart
rate, and waist and hip circumferences. Research assis-
tants were trained and followed-up to assure the quality
and validity of the measurements. Supervisors assessed
the completeness and consistency of the questionnaire
after each interview. Measuring tape was used to meas-
ure individual’s body height to the nearest to 0.1 cm,
without foot wear and any head gear. Body weight was
measured with a portable electronic weighing scale to
the nearest 0.1 kg. The participants were requested to
wear light clothes without footwear during weighing.
Waist and hip circumference were measured to the
nearest to 0.1 cm, using measuring tape. Waist circum-
ference was taken at midpoint between the lower margin
of the last palpable rib and the top of the iliac crest
(hip bone), in the standing position without clothing
and directly over the skin, according to the WHO
guideline. The hip circumference was measured to the
nearest to 0.1 cm at maximum circumference over
buttocks horizontally. Body Mass Index (BMI) was
calculated as weight in kilograms divided by the
height in meters squared.
Variables
After the questionnaire was filled in, the participants
rested 30 min before sitting blood pressure was measured
three times using the automatic sphygmomanometer
“OMRON”. The mean of the two last measurements was
used for all analyses. Hypertension was defined as systolic
blood pressure of 140 mmHg and greater or diastolic
blood pressure of 90 mmHg or greater, or currently taking
antihypertensive medications in accordance with WHO
criteria [13].
BMI was operationalized into underweight (<18.50 kg/
m2), normal weight (18.50–24.99 kg/m2) and overweight
(≥25.00 kg/m2) following WHO criteria [15]. Waist cir-
cumference (WC) cut-off points were 102 cm or greater
for men and 88 cm or greater for women according to
WHO criteria [16]. Vigorous activity was defined by ask-
ing if the participants experienced large increase in
breathing or heart rate for at least 10 min continuously.
The STEPS survey did only include questions regarding
vigorous activity at work or in recreation time, not dur-
ing travel time.
Smoking and use of smokeless tobacco were opera-
tionalized into groups consisting of those who never had
smoked tobacco or used smokeless tobacco, those who
formerly used it but have quit, and those who currently
is using it. Alcohol was operationalized into non-users
and drinkers-group.
WHO recommends a minimum of 400 g of fruit and
vegetables per day [13], which is about five daily servings.
Therefore, daily fruit and vegetable use were operational-
ized into two groups with five or more serving per day,
and less than five servings per day. Oil use was operation-
alized into groups depending on which type of oil most
often were used for meal preparation - peanut oil, palm
oil, mix of peanut and palm oil, sesame oil, or other oils.
The regions were operationalized into the four groups:
central plains, hilly, coastal and delta region. Villages
were selected for rural areas and wards were selected to
represent the urban population. Ethnicity was operation-
alized in two groups, the main ethnic group Bamar and
all the others.
Years at school were operationalized into four groups
following the school system in Myanmar. The groups
were no school, 1–5 years at school (5 years are compul-
sory), 6–11 years at school, and more than 11 years at
school (higher education). Annual income was defined
as total earnings for the household. Marital status were
operationalized into those who were currently married,
those who never have been married, and those who were
separated, divorced or widowed.
Statistical analysis
Odds ratio (OR) and 95 % confidence intervals (CIs) for
determinants of hypertension was estimated using logistic
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regression analyses. Analyses were done separately for
male and females. We identified confounders for each of
the association-outcome-relationships drawing Directed
Acyclic Graphs (DAGs) [17, 18]. Based on the DAG, for
the associations between sociodemographic variables and
hypertension all variables in Table 3 were included in ana-
lyses as confounders (i.e. age, urban/rural, region, years at
school, ethnicity). For the associations between metabolic
determinants (Body mass index and Waist circumference)
and hypertension (Table 4), we adjusted for sociodemo-
graphic confounders (age, urban/rural, region, and years
at school) and behavioral confounders (smoking status,
smokeless tobacco status, daily fruit and veg. use, oil use,
current alcohol drinkers, and vigorous activity at work).
For the associations between behavioral determinants
(smoking status, smokeless tobacco status, daily fruit and
veg. use, oil use, current alcohol drinkers, and vigorous ac-
tivity at work) and hypertension we adjusted for socio
demographic confounders (age, urban/rural, region, years
at school). Potential interaction between sex and selected
determinants on hypertension was taken care of by con-
ducting separate analyses for males and females. No inter-
action terms were included in analyses.
Prevalence estimates of hypertension were adjusted to
the WHO world standard population [14]. Level of stat-
istical significance was set to p ≤ 0.05 or 95 % CI. Data
was analyzed using the SPSS version 22 and Stata/IC 14.
Results
The prevalence of hypertension was 30 % for both sexes,
and 6 % males and 11 % females of the total population
used anti-hypertensive medications (Table 1). Mean sys-
tolic blood pressure was 5 mmHg higher for males than
for females, while there was no difference in mean dia-
stolic blood pressure. Mean BMI was low for both sexes,
21.7 kg/m2 for males and 23.0 kg/m2 for females. The
prevalence of smoking, alcohol drinking and physical ac-
tivity was considerable higher among males than females
(Table 1).
The prevalence of hypertension increase for both gen-
ders from lowest age group (15–24 years: male: 12.9 %;
female 7.5 %) to highest age group (55–64 years: male:
50.1 %; female: 53.4 %) (Table 2). Adjusted to the WHO
world population the prevalences for all ages (total) were
26.5 % (95%CI 24.9–28.2) for males and 25.2 % (23.9–
26.4) for females.
Table 3 presents associations (ORs) between selected
socio-demographic factors with hypertension, in Model
1 adjusted for age, and in Model 2 adjusted for all vari-
ables in table. In both males and females, we found that
higher age, urban living and living in Delta area was sig-
nificantly associated with increased odds for hyperten-
sion, while years at school and ethnicity were not
(Table 3, Model 2).
In fully adjusted models, both metabolic- and behav-
ioral factors were significantly associated with hyper-
tension (Table 4, Model 2). The OR for hypertension
for overweight as compared with normal weight indi-
viduals was 2.6 (95 % CI 2.1–3.3) in males and 2.3
(2.0–2.7) in females, while underweight was associated
with lower odds. Similarly, increased waist circumfer-
ence was highly significantly associated with hyperten-
sion. Smoking as compared with non-smoking was
associated with lower odds for hypertension in women
(tobacco: OR = 0.5 (0.4–0.9); smokeless tobacco: OR =
0.77 (0.6–0.9)), while alcohol drinking increased the
odds for hypertension among males only (Table 4). Use
of sesame oil in cooking as compared with use of pea-
nut oil was associated with lower odds for hypertension
in both males (OR = 0.64 (0.5–0.9) and females (OR =
0.75 (0.6–0.9). Vigorous activity at work was also asso-
ciated with lower odds for hypertension, while there
was no association between servings of fruit and vege-
tables and hypertension.
Discussion
Overall, three out of ten 15–64 year old inhabitants of
Myanmar had hypertension, with no difference between
the sexes. In fully adjusted logistic regression models,
we found increased odds for hypertension by increasing
age, and if the participants were exposed to socio-
demographic,- metabolic- and behavioral factors like
living in urban areas or the delta region, high BMI, high
WC, not doing vigorous activity at work, drinking alco-
hol (males), or non-smoking (females). Using sesame
oil in cooking as compared with peanut oil was associ-
ated with lower odds for hypertension.
Strengths of our study are the high number of partici-
pants and the large age distribution from both urban
and rural areas and the different distinct geographical
regions across the country. Data was collected using a
standardized international accepted STEPS protocol,
which may reduce potential information bias. However
this type of study, interviewing participants about life-
style factors, is prone to recall bias, which may have in-
flated our association measures. A weakness of the study
is that we do not know the extent of non-response, thus,
if the non-respondent group differs from those who con-
sent to take part in the study. This possible non-
response bias could affect the generalizability of the
study, and also the prevalence estimates could be af-
fected. In most studies, people with unhealthy habits
tend to be less willing to participate than more healthy
individuals [19]. If there is a similar trend in Myanmar,
our prevalence estimates are most likely underestimates.
Previous studies in western settings, however, have
shown that association measures are not much influ-
enced by low response rates [19].
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Another source of selection bias is due to selection of
participants from each of the households. The partici-
pant invited from each household was selected among
those who were at home at the time of investigation –
not among all those who belonged to the household.
Males may to a larger degree than females be away from
home due to work outside the house, and among elderly,
more males than females may be dead. We are unable to
estimate the magnitude of the potential bias regarding
prevalence estimates, but it is likely that more healthy
individuals are working outside the home and, thus, did
not have the chance to be included in the study. This
may have led to overestimation of the prevalences of
NCD risk factors, especially among men. We have ad-
justed prevalence estimates of hypertension to the world
standard population making data available for others to
compare, and also conducted all analyses separate for
men and women. Although the study claims to be repre-
sentative for the Union of Myanmar, another limitation
was that monks, nuns, and armed forces personnel were
not included in the present study. It is estimated that
there are between 300 000–500 000 monks in Myanmar,
Table 1 Sociodemographic and CVD risk factors among 15–64 year old citizens of Myanmar, by gender and for the total population
Male Female Total
n = 2862 n = 4457 N = 7319
Age, mean (SD) years 40.3 (13.4) 40.4 (12.8) 40.4 (13.0)
Systolic blood pressure, mmHg, mean (SD) 130.1 (19.6) 125.4 (20.8) 127.5 (20.5)
Diastolic blood pressure, mmHg, mean (SD) 80.4 (13.0) 79.6 (12.2) 79.9 (12.5)
Hypertensiona, % 30.1 29.8 29.9
Using antihypertensivesb, % 5.5 10.7 8.7








Years at school, mean (SD) 7.7 (4.0) 6.7 (4.2) 7.1 (4.1)
BMI, kg/m2, mean (SD) 21.7 (4.3) 23.0 (5.1) 22.5 (4.9)
Waist circumference, cm, mean (SD) 76.3 (10.6) 75.7 (11.2) 75.9 (11.0)
Rural, % 70.2 70.5 70.4
Region, %
Central plains 38.4 31.8 34.3
Hilly 18.4 13.8 15.6
Coastal 11.7 15.3 13.9
Delta 31.5 39.1 36.1
Ethnicity Bamar, % 73.6 72.9 73.1
Marital status, %
Currently married 73.1 67.0 21.9
Never married 23.1 21.2 69.3
Sep/Div/Wid 3.7 11.8 8.7
Currently smoking, % 44.8 7.9 22.3
Currently using smokeless tobacco, % 51.4 16.4 30.1
≥5 servings of fruit and veg. daily, % 11.0 9.8 10.2
Peanut oil use, % 41.8 42.6 42.3
Palm oil use, % 19.1 21.1 20.3
Mixed Peanut and palm oil use, % 11.7 11.1 11.3
Sesame oil use, % 18.8 17.0 17.4
Other oil use, % 9.0 8.6 8.7
Current alcohol drinkers, % 31.4 1.6 13.2
Vigorous activity at work, % 41.1 15.0 25.2
Vigorous activity in recreation time, % 12.7 2.0 6.2
aSBP ≥ 140 or DBP ≥ 90, or uses antihypertensive medications; bPercentage who uses antihypertensives by the entire population; c1 USD = 1.280 MMK, 26.
November 2015
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and 375 000 people is serving in the army [20]. It is not
known if their health situation differs from the general
population and if their exclusion has had any impact on
the results.
To conclude regarding potential selection biases: we
have probably overestimated prevalence estimates in
both male and females, but probably to a larger degree
in males, while it is likely that association measures are
valid.
Other limitations of the present study is missing infor-
mation about salt intake, a determinant for hypertension
and a potential confounder for the association between
adiposity and hypertension. Step 3 of the STEPS proto-
col, i.e. blood sampling, was not a part of the present
study, but blood lipids are most likely intermediate vari-
ables and should, thus, not be adjusted for. However, in-
formation about salt intake and analyses of lipid profiles
should be included in further studies on NCD risk fac-
tors in Myanmar. For example, ngapi, which is made by
fermenting fish or shrimp and added salt, is a main in-
gredient in the majority of Burmese cooking. It is a sort
of nutritional paste with high salt content and used as a
condiment or additive in most dishes. We recommend
studying intake of ngapi on hypertension in future sur-
veys in Myanmar. Studies have reported that the salt in-
take in South-East Asian countries is high [21], and the
increase in use of mono-sodium glutamate (MSG) could
be a major contributor to the burden of hypertension.
MSG and salt intake are highly associated with high
blood pressure [7, 22–24].
A recent published systematic review about prevalence
and risk factors of hypertension in Myanmar [10] report
a lower over-all prevalence point estimate of hyperten-
sion (22 %) as compared with the present study, but its
95 % confidence interval (14–31 %) is overlapping the
point estimate of the present study. There are some limi-
tations of the systematic review. Out of the seven in-
cluded studies, only one is recently conducted. The
others are from the start of the 2000s, and one dates
back to 1992. Thus, they used relatively old information
that does not necessarily describe the current situation
in Myanmar. At the same time, we acknowledge that
our data was collected in 2009, and may not represent
the current situation. We believe the burden of NCD
risk factors is higher today. The review [10] has in
addition included the same study two times, the
Myanmar STEPS Survey from 2003 to 2004 [25] from
Yangon division. Furthermore, it is likely that they have
not had access to original data, thus no ability to con-
sider for example outliers/odd values and exclusion of
pregnant women, although 110 pregnant women will
only have marginal impact on hypertension estimates.
In a STEPS study from Yangon Region in 2003–2004
among 20 years and older male and females, the preva-
lence of hypertension was 33.8 % [25], slightly higher
than in the present study. However, both studies found
no sex differences in prevalence rates. The higher rates
in the Yangon study, although it was conducted 5–6
years earlier, could be because they included older par-
ticipants than in the present study. When comparing
prevalence estimates age adjusted to the WHO standard
population, the prevalence of hypertension was slightly
higher in the present nationwide study (29.9 %) com-
pared with the Yangon study (27.2 %). Additionally, Yan-
gon Region is among the most developed and urbanized
parts of the country, and it’s not surprising that risk fac-
tors linked to urbanization are more unfavorable than
found in our nationwide study. Thus, due to geograph-
ical differences between the two studies, we are not able
to conclude on trends in hypertension from 2003/2004
to 2009. When comparing studies from neighboring
countries, the prevalence of hypertension in Myanmar is
at the same level as in India (29.8 %; 95 % CI 26.7–33.0)
[26], but higher than reported from Thailand (21.5 %,
19.3–23.8) [27], Bangladesh (13.5 %; 12.7–14.3) [28] and
China (26.6 %) [29]. We report higher hypertension esti-
mates in Myanmar than the overall worldwide preva-
lence, but lower than established market economies like
Spain, England, Germany and Sweden [30]. Although
Myanmar has a market oriented economy, the lower
Table 2 Prevalence of hypertension among 15–64 year old citizens of Myanmar, by age group and adjusteda to the WHO world
standard population
Age group Male Female Total
n % (95 % CI) n % (95 % CI) N % (95 % CI)
15–24 412 12.9 (10.0–16.5) 576 7.5 (5.6–9.9) 988 9.7 (8.0–11.7)
25–34 618 18.4 (15.6–21.7) 934 15.5 (13.3–18.0) 1552 16.7 (14.9–18.6)
35–44 650 29.8 (26.4–33.5) 1135 28.0 (25.5–30.7) 1785 28.7 (26.6–30.8)
45–54 649 36.5 (32.9–40.3) 1040 40.3 (37.3–43.3) 1689 38.8 (36.5–41.2)
55–64 513 50.1 (45.8–54.4) 732 53.4 (49.8–57.0) 1245 52.0 (49.3–54.8)
Total 2842 30.1 (28.4–31.8) 4417 29.8 (28.5–31.1) 7259 29.9 (28.9–31.0)
Total adja 26.5 (24.9–28.2) 25.2 (23.9–26.4) 25.7 (24.7–26.7)
a adjusted to the WHO world standard population
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Table 3 Prevalence of hypertension by gender and by sociodemographic determinants and their associations (Odds Ratio (OR)) with hypertension among 15–64 year old
citizens of Myanmar
Male Female
N No. (%) with
hypertensiona
Model 1 Model 2 N No. (%) with
hypertensiona
Model 1 Model 2
2862 OR (95 % CI) b p-value OR (95 % CI) c p-value 4457 OR (95 % CI) b p-value OR (95 % CI) c p-value
Age
15–24 415 53 (12.9) 1.00 (ref.) 1.00 (ref.) 518 43 (7.5) 1.00 (ref.) 1.00 (ref.)
25–34 619 114 (18.4) 1.53 (1.07–2.18) 0.018 1.59 (1.11–2.27) 0.01 945 145 (15.5) 2.28 (1.59–3.26) <0.001 2.3 (1.60–3.29) <0.001
35–44 657 194 (29.8) 2.88 (2.06–4.02) <0.001 2.91 (2.08–4.08) <0.001 1144 318 (28.0) 4.82 (3.45–6.76) <0.001 4.91 (3.5–6.89) <0.001
45–54 656 237 (36.5) 3.90 (2.80–5.42) <0.001 3.94 (2.82–5.52) <0.001 1049 419 (40.3) 8.36 (5.99–11.69) <0.001 8.52 (6.06–11.98) <0.001
55–64 515 257 (50.1) 6.80 (4.86–9.52) <0.001 6.86 (4.85–9.7) <0.001 738 391 (53.4) 14.21 (10.09–20.0) <0.001 14.63 (10.28–20.82) <0.001
Urban/rural
Urban 851 299 (35.3) 1.00 (ref.) 1.00 (ref.) 1311 438 (33.6) 1.00 (ref.) 1.00 (ref.)
Rural 2011 556 (27.9) 0.71 (0.59–0.85) <0.001 0.71 (0.59–0.85) <0.001 3146 878 (28.2) 0.81 (0.70–0.94) 0.004 0.81 (0.70–0.95) 0.008
Region
Central Plains 1093 294 (27.1) 1.00 (ref.) 1.00 (ref.) 1410 400 (28.6) 1.00 (ref.) 1.00 (ref.)
Hilly 534 147 (27.63) 1.26 (0.99–1.61) 0.062 1.21 (0.9–1.64) 0.198 631 183 (29.2) 1.21 (0.97–1.51) 0.062 1.09 (0.83–1.43) 0.547
Coastal 333 93 (28.62) 1.15 (0.86–1.53) 0.351 1.11 (0.79–1.57) 0.533 682 202 (30.2) 1.20 (0.97–1.49) 0.351 1.07 (0.83–1.39) 0.591
Delta 902 321 (35.8) 1.49 (1.22–1.81) <0.001 1.48 (1.21–1.8) <0.001 1734 531 (30.8) 1.20 (1.62–1.42) 0.026 1.19 (1.01–1.40) 0.038
Years at school
0 years 234 86 (36.8) 1.00 (ref.) 1.00 (ref.) 438 156 (35.9) 1.00 (ref.) 1.00 (ref.)
1–5 years 743 218 (29.6) 0.92 (0.67–1.26) 0.598 0.89 (0.64–1.22) 0.465 1810 586 (32.6) 1.12 (0.89–1.41) 0.34 1.13 (0.9–1.44) 0.283
6–11 years 1520 465 (30.8) 1.13 (0.84–1.53) 0.418 1.04 (0.76–1.42) 0.793 1700 462 (27.5) 1.22 (0.96–1.55) 0.109 1.17 (0.92–1.5) 0.207
> 11 years 365 86 (23.7) 0.94 (0.64–1.37) 0.729 0.8 (0.53–1.18) 0.264 509 112 (22.1) 1.14 (0.84–1.56) 0.395 1.08 (0.79–1.5) 0.612
Ethnicity
Bamar 2094 629 (30.0) 1.00 (ref.) 1.00 (ref.) 3238 629 (30.0) 1.00 (ref.) 1.00 (ref.)
Other ethnic 768 226 (29.4) 1.02 (0.85–1.24) 0.786 1.03 (0.85–1.24) 0.863 1219 226 (29.4) 1.16 (0.99–1.35) 0.61 1.18 (0.95–1.45) 0.132













Table 4 Prevalence of hypertension by gender and by selected metabolic- and behaviour determinants and their associations (Odds Ratio (OR)) with hypertension among 15–64




Model 1b Model 2c, d No. (%) with
hypertensiona
Model 1b Model 2c, d
N OR (95 % CI) b P-value OR (95 % CI) c, d p-value N OR (95 % CI) a p-value OR (95 % CI) c, d P-value
BMI
Underweight 569 115 (20.1) 0.66 (0.52–0.84) 0,001 0.63 (0.49–0.82) 0,001 736 118 (16.0) 0.55 (0.52–0.83) <0.001 0.56 (0.44–0.72) <0.001
Normal weight 1764 487 (27.6) 1.00 (ref.) 1.00 (ref.) 2344 581 (24.8) 1.00 (ref.) 1.00 (ref.)
Overweight 479 245 (51.2) 2.55 (2.05–3.16) <0.001 2.63 (2.08–3.33) <0.001 1304 611 (46.9) 2.36 (2.03–2.76) <0.001 2.31 (1.97–2.72) <0.001
WC
Normal 2774 819 (29.5) 1.00 (ref.) 1.00 (ref.) 3765 967 (25.7) 1.00 (ref.) 1.00 (ref.)
Male ≥102 cm, female ≥88 cm 44 30 (68.2) 3.64 (1.89–7.00) <0.001 3.4 (1.77–6.78) <0.001 617 344 (55.8) 2.83 (2.36–3.4) <0.001 2.71 (2.23–3.3) <0.001
Smoking status
Never smoker 1302 358 (27.5) 1.00 (ref.) 1.00 (ref.) 3967 1178 (29.7) 1.00 (ref.) 1.00 (ref.)
Current smoker 1270 389 (30.6) 1.05 (0.88–1.26) 0,58 1.03 (0.86–1.23) 0,719 352 99 (28.2) 0.52 (0.4–0.68) <0.001 0.53 (0.41–0.69) <0.001
Former smoker 270 108 (40) 1.25 (0.94–1.67) 0,121 1.2 (0.9–1.6) 0,196 98 39 (39.8) 0.76 (0.5–1.1) 0,206 0.77 (0.5–1.18) 0,23
Smokeless tobacco status
Never 1268 385 (30.4) 1.00 (ref.) 1.00 (ref.) 3678 1095 (29.7) 1.00 (ref.) 1.00 (ref.)
Current 1465 427 (29.2) 1.04 (0.88–1.24) 0,638 1.03 (0.84–1.24) 0,67 724 216 (29.8) 0.78 (0.66–0.95) 0,01 0.77 (0.64–0.93) 0,006
Former 109 43 (39.5) 1.45 (0.96–2.21) 0,081 1.41 (0.92–2.15) 0,117 15 6 (40.0) 1.17 (0.39–3.5) 0,769 1.1 (0.37–3.28) 0,863
Daily fruit and veg. use
≥5 servings 286 77 (26.9) 1.00 (ref.) 1.00 (ref.) 401 109 (27.2) 1.00 (ref.) 1.00 (ref.)
<5 servings 2320 703 (30.3) 1.10 (0.83–1.47) 0,506 1.06 (0.8–1.42) 3696 1104 (29.9) 1.11 (0.87–1.42) 0,381 1.13 (0.88–1.45) 0,332
Oil use
Peanut oil 1184 369 (31.2) 1.00 (ref.) 1.00 (ref.) 1873 570 (30.4) 1.00 (ref.) 1.00 (ref.)
Palm oil 534 179 (33.5) 1.11 (0.89–1.40) 0,357 1.11 (0.87–1.41) 0,406 917 293 (32.0) 1.1 0.92–1.32) 0,266 1.15 (0.95–1.4) 0,159
Mix of peanut and palm oil 326 115 (35.3) 1.09 (0.84–1.43) 0,487 71.08 (0.82–1.43) 0,582 491 160 (32.6) 1.04 (0.83–1.31) 0,693 1.07 (0.85–1.35) 0,543
Sesame oil 532 118 (22.2) 0.59 (0.46–0.76) <0.001 0.64 (0.49–0.89) 0,001 730 181 (24.8) 0.71 (0.58–0.87) 0,001 0.75 (0.60–0.94) 0,011
Other oil 249 71 (28.5) 0.91 (0.67–1.24) 0,562 0.96 (0.7–1.32) 0,803 377 105 (27.9) 0.87 (0.67–1.12) 0,293 0.89 (0.68–1.16) 0,389
Current alcohol drinkers
Drinkers 891 314 (35.3) 1.00 (ref.) 1.00 (ref.) 69 20 (29.0) 1.00 (ref.) 1.00 (ref.)
Non-drinkers 1951 541 (27.7) 0.58 (0.48–0.69) <0.001 0.57 (0.48–0.69) <0.001 4348 1296 (29.8) 0.89 (0.52–1.55) 0,707 0.94 (0.53–1.65) 0,817
Vigorous activity at work
Yes 1167 291 (24.9) 1.00 (ref.) 1.00 (ref.) 664 149 (22.4) 1.00 (ref.) 1.00 (ref.)
No 1673 563 (33.6) 1.36 (1.14–1.62) <0.001 1.33 (1.11–1.59) 0,002 3751 1167 (31.1) 1.35 (1.10–1.66) 0,003 1.33 (1.07–1.64) 0,009
a SBP ≥ 140 or DBP ≥ 90, or uses antihypertensive medications; bAdjusted for age; cBMI and WC are adjusted for age, urban/rural, region, years at school, smoking status, smokeless tobacco status, daily fruit and veg use, oil













prevalence than in other marked economies may be ex-
plained with a unfinished transformation [31] and that
the economy benefits the population unevenly [5], in
addition to health system factors and individual factors.
Our analyzes of associations between hypertension
and socio-demographic,- metabolic- and behavioral fac-
tors, show a similar pattern described in several other
studies [32, 33]. The epidemiologic transition in low in-
come countries is often explained by economic develop-
ment which leads to urbanization with a more sedentary
life style, changes in dietary habits, more smoking and
social stress [34]. It is likely that Myanmar is undergoing
a similar development.
In the Systematic review from Myanmar [10], a posi-
tive association between smoking and hypertension was
demonstrated. Surprisingly, in the present study smok-
ing was not associated with hypertension in men, and
showed an inverse relationship among women, partly
supported with findings from the STEPS study from
Yangon Region in 2003-2004 [25]. In that study, no asso-
ciation between smoking and hypertension was found,
but separate figures for male and female were not re-
ported. The present findings of a negative association in
female and no association in male call for further inves-
tigation. An association between alcohol drinking and
hypertension was found in men only, while in the Yan-
gon Region study, an association was reported with male
and females combined [25]. The prevalence of alcohol
drinking among women in Myanmar is low, due to cul-
ture, tradition and the Buddhist religion, and calls for
sex-stratified analyses. The same applies to analyses of
smoking.
Our findings of overweight and low physical activity as
determinants of hypertension support previous studies
from Myanmar [25] and further support a general view
that adiposity is a major determinant of hypertension
[35]. A recent study of relatively lean rural adults in
southwest of China reported that general adiposity in
terms of higher BMI is more strongly associated with
hypertension than waist circumference [36]. In the
present study we found an opposite tendency, that waist
circumference is more strongly associated with hyper-
tension than BMI above 25 kg/m2. The failure of finding
an association between hypertension and low levels of
fruit and vegetables in the present study and the scarcity
of studies from low income countries calls for more re-
search. Our finding of lower odds for hypertension
among those who report use of sesame oil for cooking,
as compared with peanut oil supports previous studies
of the beneficial effect of sesame oil in reduction of
blood pressure in hypertensive patients [37].
Given a continuous economic development in Myanmar,
and if preventive policies for NCDs are not put in place,
we may expect a similar epidemiologic transition in
Myanmar as in other Asian countries, like for example the
well documented NCD trends in China [38]. The develop-
ment seen in Singapore during the past several decades
could also indicate future prospects of Myanmar: a rapid
urbanization and economic development, with a demo-
graphic transition concomitant with an epidemiological
transition, leading to an increase in cardio vascular dis-
eases and their associated factors [3]. There is available
evidence for health promoting interventions in reducing
NCD risk in low income setting [39], which could be con-
sidered in plans for NCD policies in Myanmar.
Conclusions
We conclude that the prevalence of hypertension among
15–64 year old citizens of Myanmar is high and associ-
ated with socio-demographic,- metabolic- and behav-
ioural factors. However, prevalence estimates may have
been overestimated due to several sources of potential
selection biases. Future studies on NCD risk factors
should pay attention to sampling procedures to reduce
biases. The large group of military people, monks and
nuns should be included in new studies in order to make
a sample representative for the population of Myanmar.
Alcohol intake, smoking and nutritional factors includ-
ing salt intake, should be investigated in more detail.
Public health implications
The prevalences of hypertension and associated factors are
high and probably increasing. We recommend studies on
effectiveness on interventions and immediate implementa-
tion of policies to reduce the burden of NCD risk based
on programs proven effective in similar settings [39].
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